Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2

Author:

Hijikata Atsushi1ORCID,Shionyu‐Mitsuyama Clara1,Nakae Setsu1,Shionyu Masafumi1ORCID,Ota Motonori2ORCID,Kanaya Shigehiko3ORCID,Hirokawa Takatsugu456ORCID,Nakajima Shogo7,Watashi Koichi789,Shirai Tsuyoshi1ORCID

Affiliation:

1. Faculty of Bioscience Nagahama Institute of Bio‐Science and Technology Japan

2. Department of Complex Systems Science Graduate School of Informatics Nagoya University Japan

3. Computational Biology Laboratory Division of Information Science Graduate School of Science and Technology Nara Institute of Science and Technology (NAIST) Ikoma Japan

4. Division of Biomedical Science Faculty of Medicine University of Tsukuba Japan

5. Transborder Medical Research Center University of Tsukuba Japan

6. Cellular and Molecular Biotechnology Research Institute National Institute of Advanced Industrial Science and Technology Tokyo Japan

7. Department of Virology II National Institute of Infectious Diseases Shinjuku‐ku Japan

8. Research Center for Drug and Vaccine Development National Institute of Infectious Diseases Shinjuku‐ku Japan

9. Department of Applied Biological Sciences Tokyo University of Science Noda Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3